Face-to-face Versus Online Hypnotherapy for the Treatment of Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Other: Face-to-face hypnotherapy;   Other: Online hypnotherapy;   Other: Online psychoeducation Sponsors:   Maastricht University Medical Center;   ZonMw: The Netherlands Organisation for Health Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2019 Category: Research Source Type: clinical trials

The Effect of Gluten in Patients With Irritable Bowel Syndrome and Healthy Volunteers
Condition:   Irritable Bowel Syndrome Interventions:   Other: Gluten-free diet with gluten powder;   Other: Gluten-free diet with placebo powder Sponsor:   Sahlgrenska University Hospital, Sweden Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2019 Category: Research Source Type: clinical trials

Panaceo " MED " for IBS (Irritable Bowel Syndrome)
Conditions:   Irritable Bowel Syndrome;   Microbial Colonization;   Intestinal Disease Intervention:   Other: Zeolite Sponsor:   Scigenia GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials

Interest of Pan-capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
Condition:   Irritable Bowel Syndrome With Diarrhea Intervention:   Other: Pan Capsule and colonoscopy in patients with IBS Sponsors:   Hospital Avicenne;   Adeprina Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 16, 2019 Category: Research Source Type: clinical trials